Clinical Trial Update: Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study [Phase 3]

View source ↗

Summary

Pilot prospective cohort study evaluating rivaroxaban for treatment of splanchnic vein thrombosis including portal, mesenteric, and splenic vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesenteric Vein Thrombosis
• Portal Vein Thrombosis
• Splenic Vein Thrombosis

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Università degli Studi dell'Insubria | Conditions: Portal Vein Thrombosis, Mesenteric Vein Thrombosis | Phase 3 | Status: UNKNOWN